Literature DB >> 16847088

Prevention and self-treatment of traveler's diarrhea.

David J Diemert1.   

Abstract

Of the millions who travel from the industrialized world to developing countries every year, between 20% and 50% will develop at least one episode of diarrhea, making it the most common medical ailment afflicting travelers. Although usually a mild illness, traveler's diarrhea can result in significant morbidity and hardship overseas. Precautions can be taken to minimize the risk of developing traveler's diarrhea, either through avoidance of potentially contaminated food or drink or through various prophylactic measures, including both nonpharmacological and antimicrobial strategies. If diarrhea does develop despite the precautions taken, effective treatment-usually a combination of an antibiotic and an antimotility agent-can be brought by the traveler and initiated as soon as symptoms develop. In the future, vaccines-several of which are in the advanced stages of clinical testing-may be added to the list of prophylactic measures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847088      PMCID: PMC1539099          DOI: 10.1128/CMR.00052-05

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  167 in total

1.  Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers.

Authors: 
Journal:  J Travel Med       Date:  1997-03-01       Impact factor: 8.490

2.  Enteroinvasive Escherichia coli in travelers with diarrhea.

Authors:  A R Wanger; B E Murray; P Echeverria; J J Mathewson; H L DuPont
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

3.  Traveller's diarrhea among Austrian tourists in warm climate countries: I. Epidemiology.

Authors:  H Kollaritsch
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

4.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

5.  Efficacy and toxicity of fleroxacin in the treatment of travelers' diarrhea.

Authors:  R Steffen; R Jori; H L DuPont; J J Mathewson; D Stürchler
Journal:  Am J Med       Date:  1993-03-22       Impact factor: 4.965

Review 6.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 7.  Bismuth subsalicylate in the treatment and prevention of diarrheal disease.

Authors:  H L DuPont
Journal:  Drug Intell Clin Pharm       Date:  1987-09

Review 8.  Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.

Authors:  C Scarpignato; P Rampal
Journal:  Chemotherapy       Date:  1995       Impact factor: 2.544

9.  Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance.

Authors:  Jordi Vila; Joaquin Ruiz; Francisco Gallardo; Martha Vargas; Lara Soler; Maria José Figueras; Joaquin Gascon
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

10.  Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli.

Authors:  C Eslava; F Navarro-García; J R Czeczulin; I R Henderson; A Cravioto; J P Nataro
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more
  23 in total

Review 1.  Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.

Authors:  Felice Schnoll-Sussman; Philip O Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

2.  Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.

Authors:  Yuleima Diaz; Morten L Govasli; Ephrem Debebe Zegeye; Halvor Sommerfelt; Hans Steinsland; Pål Puntervoll
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

3.  Epidemiology and self-treatment of travelers' diarrhea in a large, prospective cohort of department of defense beneficiaries.

Authors:  Tahaniyat Lalani; Jason D Maguire; Edward M Grant; Jamie Fraser; Anuradha Ganesan; Mark D Johnson; Robert G Deiss; Mark S Riddle; Timothy Burgess; David R Tribble
Journal:  J Travel Med       Date:  2014-12-07       Impact factor: 8.490

4.  Antibiotic Therapy for Acute Watery Diarrhea and Dysentery.

Authors:  David R Tribble
Journal:  Mil Med       Date:  2017-09       Impact factor: 1.437

5.  Preface: Guidelines for the Treatment of Travelers' Diarrhea in Deployed Military Personnel.

Authors:  Mark S Riddle; David Tribble
Journal:  Mil Med       Date:  2017-09       Impact factor: 1.437

6.  A small-scale experiment of using phage-based probiotic dietary supplement for prevention of E. coli traveler's diarrhea.

Authors:  A V Aleshkin; E O Rubalskii; N V Volozhantsev; V V Verevkin; E A Svetoch; I A Kiseleva; S S Bochkareva; O Yu Borisova; A V Popova; A G Bogun; S S Afanas'ev
Journal:  Bacteriophage       Date:  2015-07-24

Review 7.  Resistant pathogens as causes of traveller's diarrhea globally and impact(s) on treatment failure and recommendations.

Authors:  David R Tribble
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

8.  Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.

Authors:  Mark S Riddle; Patrick Connor; Jamie Fraser; Chad K Porter; Brett Swierczewski; Emma J Hutley; Brook Danboise; Mark P Simons; Christine Hulseberg; Tahaniyat Lalani; Ramiro L Gutierrez; David R Tribble
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

9.  The prevalence of enterotoxigenic e. Coli isolated from the stools of children aged 0-10 years with diarrhea in mid-anatolia region, Turkey.

Authors:  Latife Işeri; Teoman Zafer Apan; Altan Aksoy; Figen Koç; Jülide Sedef Göçmen; Diba Nuristani
Journal:  Braz J Microbiol       Date:  2011-01       Impact factor: 2.476

10.  Incidence of and risk factors for hospital-acquired diarrhea in three tertiary care public hospitals in Bangladesh.

Authors:  Mejbah Uddin Bhuiyan; Stephen P Luby; Rashid Uz Zaman; M Waliur Rahman; M A Yushuf Sharker; M Jahangir Hossain; Choudhury H Rasul; A R M Saifuddin Ekram; Mahmudur Rahman; Katharine Sturm-Ramirez; Eduardo Azziz-Baumgartner; Emily S Gurley
Journal:  Am J Trop Med Hyg       Date:  2014-04-28       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.